(P039) Dose-Dependent Change in T2 Relaxation Time Constant in Sarcoma and Normal Tissue

Publication
Article
OncologyOncology Vol 30 No 4_Suppl_1
Volume 30
Issue 4_Suppl_1

Our results demonstrate that there is a measurable T2 relaxation time constant change in retroperitoneal sarcoma after 28 Gy.

Chenyang Wang, MD, PhD, Yingli Yang, PhD, Minsong Cao, PhD,  Daniel Low, PhD, Mitchell Kamrava, MD; Department of Radiation  Oncology, UCLA

INTRODUCTION: Magnetic resonance imaging (MRI) T2 relaxation time constant mapping is a technique that characterizes T2 relaxation curve via exponential fitting of T2-weighted MR images at different echo times, and the resulting relaxation time constant has been shown to correlate with macromolecular property of physiological tissue.

METHODS: The MRI plan was approved by the institutional review board at our institution. MRI was carried out on a 0.35T whole body MRI scanner before and after preoperative radiation to retroperitoneal sarcoma for 28 Gy in eight fractions. Pulse sequence consists of a turbo spin echo (TSE) sequence with TR of 2,000 ms, TE = [28, 56, 98, 140] ms, matrix = 256 × 256 × 10, slice thickness = 1.5 mm, average = 4, and turbo factor = 10. A T2 relaxation time constant map was generated by applying voxel-by-voxel exponential fitting for images acquired at each TE. Regions of interest, including tumor, iliac bone, and iliacus muscles, were drawn on T2-weighted images and applied to the T2 relaxation time constant map to extract mean T2 relaxation time constant values for each structure.

RESULTS: Retroperitoneal sarcoma demonstrated a significant increase in mean T2 relaxation time constant after 28 Gy, with a mean increase of 14.02% (P < .05). Ipsilateral iliac bone adjacent to the sarcoma showed a decrease in T2 of 20.33%, while the contralateral side showed a minimal change of 1.71% (P < .0005).

DISCUSSION: Our results demonstrate that there is a measurable T2 relaxation time constant change in retroperitoneal sarcoma after 28 Gy. In addition, normal tissue, such as the iliac bone, appears to demonstrate a significant dose-dependent change in T2, since only the ipsilateral iliac bone near the radiation field exhibited significant change. Our results indicate that T2 measurement has the potential to characterize tumor and normal tissue responses to radiation.

Proceedings of the 98th Annual Meeting of the American Radium Society -americanradiumsociety.org

Articles in this issue

(S002) A 15-Year Review of Radiation Therapy for Keloids at Two Institutions
(S003) Single-Fraction Radiation Therapy for the Treatment of Multiple Myeloma Bony Metastases Provides Pain Control and Decreases Time to Chemotherapy
(S001) Prognostic Value of Pretreatment Serum Inflammatory Markers in Patients Receiving Radiation Therapy for Oropharyngeal Cancer
(S004) Trend in Second Malignancy Risk for Head and Neck Cancer With Increased Utilization of IMRT: Analysis of SEER Database
(S005) Comparison of Legal Needs of a Group of Patients With Cancer: Economic and Geographic Factors
(S006) Mission Improvement: Lessons From Initiating a Resident-Led Quality Improvement Project on Smoking Cessation at a County Hospital
(S007) Results of a Phase II Trial Using Cetuximab Plus Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma
(S008) The Effect of Simulation and Treatment Delays for Patients With Oropharyngeal Cancer Receiving Definitive Radiation Therapy in the Era of Risk Stratification Using Smoking and Human Papilloma Virus Status
(S009) Intensity-Modulated Radiation Therapy With Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on Three-Year Toxicity
(S011) Comparative Study Between Ileal Conduit and Indiana Pouch After Cystectomy for Patients With Carcinoma of Urinary Bladder
(S010) Computed Tomography–Assessed Measures of Bone Mineral Density and Muscle Mass as Predictors of Survival in Men With Prostate Cancer
(S012) Quantitative Imaging to Evaluate the Malignant Potential of Pancreatic Cysts
(S013) Spine Stereotactic Radiosurgery With Concurrent Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
(S014) The Impact of Radiation Therapy on Survival in Surgically Resected, High-Risk Patients With Ampullary Adenocarcinoma: A Population-Based Analysis
(S016) The Impact of Stereotactic Body Radiation Therapy on Overall Survival in Patients With Locally Advanced Pancreatic Cancer
Recent Videos
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
Although accuracy remains a focus in whole-body MRI testing in patients with Li-Fraumeni syndrome, comfortable testing experiences may ease anxiety.
Subsequent testing among patients in a prospective study may affirm the ability of cfDNA sequencing to detect cancers in those with Li-Fraumeni syndrome.
cfDNA sequencing may allow for more accessible, frequent, and sensitive testing compared with standard surveillance in Li-Fraumeni syndrome.
STX-478 showed efficacy in patients with advanced solid tumors regardless of whether they had kinase domain or helical PI3K mutations.
STX-478 may avoid adverse effects associated with prior PI3K inhibitors that lack selectivity for the mutated protein vs the wild-type protein.
Phase 1 data may show the possibility of rationally designing agents that can preferentially target PI3K mutations in solid tumors.
Funding a clinical trial to further assess liquid biopsy in patients with Li-Fraumeni syndrome may help with detecting cancers early across the board.
Michael J. Hall, MD, MS, FASCO, discusses the need to reduce barriers to care for those with Li-Fraumeni syndrome, including those who live in rural areas.
Related Content